VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,706,000 | +34.4% | 62,670 | -5.5% | 0.00% | +50.0% |
Q1 2019 | $1,269,000 | +104.7% | 66,300 | +0.5% | 0.00% | +100.0% |
Q4 2018 | $620,000 | -50.9% | 66,000 | -1.2% | 0.00% | -50.0% |
Q3 2018 | $1,264,000 | -28.1% | 66,790 | -25.8% | 0.00% | -33.3% |
Q2 2018 | $1,759,000 | – | 90,010 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
Birchview Capital, LP | 30,000 | $516,000 | 0.34% |